Compare LRMR & FRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LRMR | FRPH |
|---|---|---|
| Founded | N/A | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 455.8M | 435.3M |
| IPO Year | 2014 | 1995 |
| Metric | LRMR | FRPH |
|---|---|---|
| Price | $5.00 | $22.16 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $16.50 | N/A |
| AVG Volume (30 Days) | ★ 2.0M | 72.7K |
| Earning Date | 04-29-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.16 |
| Revenue | N/A | ★ $41,774,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,816.14 | N/A |
| P/E Ratio | ★ N/A | $137.88 |
| Revenue Growth | N/A | ★ 0.65 |
| 52 Week Low | $1.61 | $20.53 |
| 52 Week High | $6.42 | $28.45 |
| Indicator | LRMR | FRPH |
|---|---|---|
| Relative Strength Index (RSI) | 57.54 | 48.08 |
| Support Level | $3.14 | $20.53 |
| Resistance Level | $5.37 | $24.59 |
| Average True Range (ATR) | 0.31 | 0.79 |
| MACD | -0.02 | 0.13 |
| Stochastic Oscillator | 90.66 | 58.48 |
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).